Skip to main content

Woodline Partners LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
127,028
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. ESPR ranks #16 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 127,028
2026-03-31 127,028
2025-12-31 127,030
2025-09-30 382,087
2025-06-30 1,503,754
2025-03-31 1,503,754
2024-12-31 1,503,746
2024-09-30 2,244,360
2024-06-30 5,049,808
2024-03-31 7,922,229
2023-12-31 290,382
2023-03-31 423,814
2022-12-31 423,814
2022-09-30 1,195,705
2022-06-30 844,635